Effect Of Low Frequency Ultrasound Plus Fluorescent Composite Carrier In The Diagnosis And Treatment Of Methicillin-Resistant Staphylococcus Aureus Biofilm Infection Of Bone Joint Implant

Huajun Zhou,Shiyuan Fang,Rong Kong,Weiwei Zhang,Kerong Wu,Rui Xia,Xifu Shang,Chen Zhu
2018-01-01
Abstract:Objective: To study the curative effect of low frequency ultrasound targeted radiation plus self-prepared human beta-defensins-3 (HBD-3) lipidosome microbubble fluorescent composite carrier for methicillin-resistant Staphylococcus aureus (MRSA) biofilm infection of intra-articular implant from an animal experiment based on the primary mechanism of the long-lasting recurrence of intra-articular implant infection (bacterial biofilm and bacterial internalization). Methods: Ti sheet and MRSA were co-cultivated for 24 hours. After the formation of biofilm, they were placed on both sides of dorsal spine of mice subcutaneously. These mice were divided into 6 groups (6 mice for each group) according to the form of carrier, which were HBD-3 group (Group A), HBD-3 fluorescent liposome group (Group B), HBD-3 lipidosome-microbubble fluorescent composite carrier group (Group C), low frequency ultrasound + HBD-3 group (Group D), low frequency ultrasound + HBD-3 fluorescent liposome group (Group E) and low frequency ultrasound + HBD-3 lipidosome-microbubble fluorescent composite carrier group (Group F). The remaining viable bacteria quantities in biofilm under different experimental treatment conditions were observed through coated sheet count, laser scanning confocal microscope and electron microscope. The relevant film-forming genes and drug resistant genes were analyzed quantitatively and statistically by real-time PCR. Results: Compared with other groups, the remaining viable bacteria percentage of Group F was significantly dropped, and the differences had statistical significance (P<0.05). The gene expression of Group F was higher than other groups, showing statistically significant differences (P<0.05). Conclusion: Low frequency ultrasound + HBD-3 lipidosome microbubble fluorescent composite carrier can greatly enhance the killing effect of HBD-3 to drug resistant staphylococcus in biofilm and inhibit the further maturity of bio-film. It also can help to treat MRSA biofilm infection in femoral implant of rats, thus providing a new thought for the current antibiotic treatment of bone and joint infection, and increasing the diagnosis rate and cure rate of implant infection at early stage in bone joint.
What problem does this paper attempt to address?